CPRX - Catalyst Pharmaceuticals Q3 Earnings Preview

November, 11 2019 05:35 PM Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals (NASDAQ:CPRX) is scheduled to announce Q3 earnings results on Tuesday, November 12th, after market close.
The consensus EPS Estimate is $0.11 (+237.5% Y/Y) and the consensus Revenue Estimate is $33.19M
Over the last 2 years, cprx has beaten EPS estimates 50% of the time and has beaten revenue estimates 0% of the time.
Over the last 3 months, EPS estimates have seen 4 upward revisions and 0 downward. Revenue estimates have seen 5 upward revisions and 0 downward.
More news on: Catalyst Pharmaceuticals, Inc., Earnings news and commentary, , Healthcare stocks news,

Company Name:	Catalyst Pharmaceuticals Inc.
Stock Symbol:	CPRX
Market:	NASDAQ
Website:	catalystpharma.com